Leishmania aethiopica cell‐to‐cell spreading involves caspase‐3, AkT, and NF‐κB but not PKC‐δ activation and involves uptake of LAMP‐1‐positive bodies containing parasites

Development of human leishmaniasis is dependent on the ability of intracellular Leishmania parasites to spread and enter macrophages. The mechanism through which free promastigotes and amastigotes bind and enter host macrophages has been previously investigated; however, little is known about intracellular trafficking and cell‐to‐cell spreading. In this study, the mechanism involved in the spreading of Leishmania aethiopica and Leishmania mexicana was investigated. A significant increase in phosphatidylserine (PS) exhibition, cytochrome C release, and active caspase‐3 expression was detected (P < 0.05) during L. aethiopica, but not L. mexicana spreading. A decrease (P < 0.05) of protein kinase B (Akt) protein and BCL2‐associated agonist of cell death (BAD) phosphorylation was also observed. The nuclear factor kappa‐light‐chain enhancer of activated B cells (NF‐kB) signaling pathway and pro‐apoptotic protein protein kinase C delta (PKC‐δ) were downregulated while inhibition of caspase‐3 activation prevented L. aethiopica spreading. Overall suggesting that L. aethiopica induces host cell’s apoptosis during spreading in a caspase‐3‐dependent manner. The trafficking of amastigotes within macrophages following cell‐to‐cell spreading differed from that of axenic parasites and involved co‐localization with lysosomal‐associated membrane protein 1 (LAMP‐1) within 10 min postinfection. Interestingly, following infection with axenic amastigotes and promastigotes, co‐localization of parasites with LAMP‐1‐positive structures took place at 1 and 4 h, respectively, suggesting that the membrane coat and LAMP‐1 protein were derived from the donor cell. Collectively, these findings indicate that host cell apoptosis, demonstrated by PS exhibition, caspase‐3 activation, cytochrome C release, downregulation of Akt, BAD phosphorylation, NF‐kB activation, and independent of PKC‐δ expression, is involved in L. aethiopica spreading. Moreover, L. aethiopica parasites associate with LAMP‐rich structures when taken up by neighboring macrophages.

[1]  L. Harbige,et al.  Apoptotic induction induces Leishmania aethiopica and L. mexicana spreading in terminally differentiated THP-1 cells , 2017, Parasitology.

[2]  W. Dutra,et al.  Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis , 2015, PloS one.

[3]  R. Mortara,et al.  Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions , 2014, Cellular microbiology.

[4]  A. Deacon,et al.  Development and validation of four Leishmania species constitutively expressing GFP protein. A model for drug discovery and disease pathogenesis studies , 2013, Parasitology.

[5]  C. Roy,et al.  Pathogen signatures activate a ubiquitinylation pathway that modulates function of the metabolic checkpoint kinase mTOR , 2013, Nature Immunology.

[6]  A. Kassahun,et al.  Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model. , 2013, Experimental parasitology.

[7]  Marie W Pettit,et al.  Imaging select mammalian organelles using fluorescent microscopy: application to drug delivery. , 2013, Methods in molecular biology.

[8]  M. Wilson,et al.  Stage-Specific Pathways of Leishmania infantum chagasi Entry and Phagosome Maturation in Macrophages , 2011, PloS one.

[9]  P. Dyer,et al.  Delivery of biologics to select organelles – the role of biologically active polymers , 2011, Expert opinion on drug delivery.

[10]  W. Sellers,et al.  Drug discovery approaches targeting the PI3K/Akt pathway in cancer , 2008, Oncogene.

[11]  R. Cheke,et al.  Induction of apoptosis in host cells: a survival mechanism for Leishmania parasites? , 2008, Parasitology.

[12]  R. Duncan,et al.  The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[13]  M. Olivier,et al.  A novel form of NF‐κB is induced by Leishmania infection: Involvement in macrophage gene expression , 2008, European journal of immunology.

[14]  Erwig Lp,et al.  Clearance of apoptotic cells by phagocytes. , 2008 .

[15]  T. Holzer,et al.  Global gene expression in Leishmania. , 2007, International journal for parasitology.

[16]  Nicole A. Leal,et al.  Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis , 2007, Cellular microbiology.

[17]  S. Akira,et al.  VP1686, a Vibrio Type III Secretion Protein, Induces Toll-like Receptor-independent Apoptosis in Macrophage through NF-κB Inhibition* , 2006, Journal of Biological Chemistry.

[18]  A. Gudkov,et al.  Proteolytic Cleavage of the p65-RelA Subunit of NF-κB during Poliovirus Infection* , 2005, Journal of Biological Chemistry.

[19]  M. Panaro,et al.  Infection with Leishmania infantum Inhibits Actinomycin D‐Induced Apoptosis of Human Monocytic Cell Line U‐937 , 2005, The Journal of eukaryotic microbiology.

[20]  A. Gebert,et al.  Cutting Edge: Neutrophil Granulocyte Serves as a Vector for Leishmania Entry into Macrophages1 , 2004, The Journal of Immunology.

[21]  R. Madhubala,et al.  Leishmania donovani activates nuclear transcription factor-kappaB in macrophages through reactive oxygen intermediates. , 2004, Biochemical and biophysical research communications.

[22]  G. H. Coombs,et al.  Inhibition of Lipopolysaccharide-Induced Macrophage IL-12 Production by Leishmania mexicana Amastigotes: The Role of Cysteine Peptidases and the NF-κB Signaling Pathway1 , 2004, The Journal of Immunology.

[23]  J. Estaquier,et al.  Leishmania major‐mediated prevention of programmed cell death induction in infected macrophages is associated with the repression of mitochondrial release of cytochrome c , 2004, Journal of leukocyte biology.

[24]  K. Ravichandran,et al.  Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. , 2003, Trends in cell biology.

[25]  L. Garraway,et al.  The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Daleke.  Regulation of transbilayer plasma membrane phospholipid asymmetry Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.R200019-JLR200 , 2003, Journal of Lipid Research.

[27]  P. Roux,et al.  Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. , 2002, Journal of cell science.

[28]  N. Goyal,et al.  In vitro cultivation and characterization of axenic amastigotes of Leishmania. , 2001, Trends in parasitology.

[29]  D. James,et al.  Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion. , 2000, Molecular biology of the cell.

[30]  J. Cruz,et al.  Macrophage Damage by Leishmania amazonensis Cytolysin: Evidence of Pore Formation on Cell Membrane , 2000, Infection and Immunity.

[31]  Y. Belkaid,et al.  A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.

[32]  M. Desjardins,et al.  Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis , 2000, Cellular microbiology.

[33]  S. Méresse,et al.  Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes , 1999, Cellular microbiology.

[34]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[35]  M. Neurath,et al.  The yopJ locus is required for Yersinia‐mediated inhibition of NF‐κB activation and cytokine expression: YopJ contains a eukaryotic SH2‐like domain that is essential for its repressive activity , 1998, Molecular microbiology.

[36]  R. Mortara,et al.  Axenic cultivation and partial characterization of Leishmania braziliensis amastigote-like stages , 1998, Parasitology.

[37]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[38]  M. Desjardins,et al.  Inhibition of Phagolysosomal Biogenesis by the Leishmania Lipophosphoglycan , 1997, The Journal of experimental medicine.

[39]  Keisuke Kuida,et al.  Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[40]  D. Mcmahon-Pratt,et al.  Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms. , 1996, Experimental parasitology.

[41]  P. Kaye,et al.  Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. , 1994, Journal of cell science.

[42]  D. Mcmahon-Pratt,et al.  Developmental Life Cycle of Leishmania—Cultivation and Characterization of Cultured Extracellular Amastigotes 1 , 1993, The Journal of eukaryotic microbiology.

[43]  H. Akuffo.  Cytokine Responses to Parasite Antigens: In Vitro Cytokine Production to Promastigotes of L. aethiopica by Cells from Non‐Leishmania Exposed Donors may Influence Disease Establishment , 1992, Scandinavian journal of immunology. Supplement.

[44]  J. Abita,et al.  Interactions between the human monocytic leukaemia THP-1 cell line and Old and New World species of Leishmania. , 1990, Acta tropica.

[45]  A. Pan.  Leishmania mexicana: serial cultivation of intracellular stages in a cell-free medium. , 1984, Experimental parasitology.